ArticleScientific reports2026
Artificial neural network as a strategy to predict rheological properties in emulgel formulations.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents an innovative approach that combines quality by design (QbD) principles with artificial neural networks (ANNs) to predict and optimize the formulation of carbopol-based emulsions. By integrating these two strategies, we enhance our understanding of formulations by linking critical material attributes and process parameters to critical quality attributes, such as viscosity. The predictive model was refined by selecting key variables: mixing time, mixing speed, and viscosity. These variables were used to estimate carbopol concentration and to capture the nonlinear relationships that influence emulsion behavior. Experimental data were employed to train, validate, and test the ANN model, which was then compared with four commercial formulations to evaluate its predictive accuracy and practical relevance. Notably, the model demonstrated excellent predictive performance for systems with viscosities exceeding 50,000 mPas, underscoring its applicability to high-viscosity pharmaceutical products. This integrated QbD-ANN framework offers a systematic and effective method for formulation optimization, reducing experimental workloads while improving process understanding. The findings indicate a strong correlation between predicted and experimental values, confirming the robustness and reliability of the QbD-ANN approach. Integrating the three key variables enables a more in-depth examination of the interactions between process and formulation, providing a comprehensive tool for understanding and controlling emulsion viscosity. In conclusion, this study establishes a data-driven methodology that facilitates rational pharmaceutical development, ensuring product quality, reproducibility, and innovation in alignment with modern pharmaceutical quality management principles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.